At Harvard Medical School, I study clonal mixing across breast, colorectal, pancreatic, and other cancers using multi-region whole-exome sequencing. I analyze purity, ploidy, copy number, and cancer cell fractions to support clonal deconvolution.
I also study selection in breast tissue by calling somatic mutations from duplex sequencing and estimating selection with dN/dS. For this work, I prepare NGS libraries and test NanoSeq and TWIST protocol variants.
At Yale School of Public Health, I estimated neutral mutation rates and cancer effect sizes across tumor types, separating how often a variant arises from how strongly it is selected. I also built a workflow to phase poly-G repeat variants and detect clonal expansions or distinguish independent mutation events.
My PhD research at Indiana University focused on germline mutation rates and parental sex bias using pedigree whole-genome sequencing. I’ve also analyzed RNA-seq and small RNA-seq data, contributed to CAGEE, and co-authored peer-reviewed work across evolutionary and cancer genomics.

